Glucose transporters of the glomerulus and the implications for diabetic nephropathy
- PMID: 9285909
Glucose transporters of the glomerulus and the implications for diabetic nephropathy
Abstract
Several glucose transporters have recently been identified in glomeruli, and in cultured glomerular cells. These include the facilitative glucose transporter isoforms GLUTs 1, 3 and 4, and sodium-glucose cotransport activity with characteristics of SGLT1. GLUTs 1, 3 and 4 are all high affinity, low capacity, facilitative glucose transporters which typically would be saturated at or near physiologic glucose concentrations. The SGLT transporter of mesangial cells is also a high affinity transporter which similarly could be saturated under normal glucose conditions. This suggests that in order for mesangial cells to take up excessive quantities of glucose in diabetes, changes in glucose transporter expression, translocation or activity may be required. Accordingly, recent investigations discovered positive-feedback regulation of the mesangial cell GLUT1 transporter by glucose, and a regulatory role for GLUT1 in glucose metabolism and extracellular matrix synthesis. Future investigations of glucose transporters in the pathogenesis of diabetic renal disease will now likely proceed in multiple directions, including but not limited to: (1) examination of their regulation by growth factors implicated in diabetic nephropathy, and the resultant effects on ECM synthesis; (2) determination of the mechanisms by which GLUT1 regulates the expression of aldose reductase, PKC, GLUT1, and other genes in the mesangial cell; and (3) Suppression of glucose transporters in attempts to prevent high glucose-induced diabetic glomerulosclerosis.
Similar articles
-
Role for GLUT1 in diabetic glomerulosclerosis.Expert Rev Mol Med. 2006 Feb 6;8(4):1-18. doi: 10.1017/S1462399406010490. Expert Rev Mol Med. 2006. PMID: 16515729 Review.
-
[The role of cellular glucose transporters in pathogenesis of diabetic nephropathy].Przegl Lek. 1999;56(12):793-9. Przegl Lek. 1999. PMID: 10789192 Review. Polish.
-
Identification and function of glucose transporter 1 in human mesangial cells.Chin Med J (Engl). 2001 Aug;114(8):824-8. Chin Med J (Engl). 2001. PMID: 11780359
-
[Phenotypic and functional alterations of mesangial cells in patients with diabetic nephropathy].Zhonghua Yi Xue Za Zhi. 2001 Nov 25;81(22):1369-73. Zhonghua Yi Xue Za Zhi. 2001. PMID: 11930630 Chinese.
-
[Regulation of the expression and function of glucose transporter-1 by TGF-beta 1 and high glucose in mesangial cells].Chin Med J (Engl). 2000 Jun;113(6):508-13. Chin Med J (Engl). 2000. PMID: 11775867 Chinese.
Cited by
-
In situ protein Kinase C activity is increased in cultured fibroblasts from Type 1 diabetic patients with nephropathy.Diabetologia. 2003 Apr;46(4):524-30. doi: 10.1007/s00125-003-1061-4. Epub 2003 Mar 26. Diabetologia. 2003. PMID: 12739026
-
Diabetes increases facilitative glucose uptake and GLUT2 expression at the rat proximal tubule brush border membrane.J Physiol. 2003 Nov 15;553(Pt 1):137-45. doi: 10.1113/jphysiol.2003.046268. Epub 2003 Sep 8. J Physiol. 2003. PMID: 12963802 Free PMC article.
-
Effects of High Glucose on Simulated Ischemia/Reperfusion Injury in Isolated Cardiomyocytes.Int J Mol Sci. 2025 Jun 24;26(13):6050. doi: 10.3390/ijms26136050. Int J Mol Sci. 2025. PMID: 40649827 Free PMC article.
-
Prompt apoptotic response to high glucose in SGLT-expressing renal cells.Am J Physiol Renal Physiol. 2019 May 1;316(5):F1078-F1089. doi: 10.1152/ajprenal.00615.2018. Epub 2019 Mar 13. Am J Physiol Renal Physiol. 2019. PMID: 30864838 Free PMC article.
-
Metabolic reprogramming: A novel therapeutic target in diabetic kidney disease.Front Pharmacol. 2022 Sep 2;13:970601. doi: 10.3389/fphar.2022.970601. eCollection 2022. Front Pharmacol. 2022. PMID: 36120335 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous